Back
HFA Premium Access

Does a clinical scientist led cardio-oncology clinic improve surveillance for cardio-toxicity for patients receiving trastuzumab compared to oncology services alone?

Session: Poster Session 4 - Cardiovascular Disease in Special Populations
Topic: Cardio-Oncology
Speaker: Miss J. Draper (London, GB)
Event: Heart Failure 2019

Congress Presentation

Add to my library

Like

About the speaker

Miss Jane Draper

St Thomas', London (United Kingdom of Great Britain & Northern Ireland)
0 follower

9 more presentations in this session

Clinical features of immune checkpoint inhibitor-related cardiotoxicity

Speaker: Doctor Y. Kirichenko (Moscow, RU)

Access
Abstract
Like
Thumbnail

The prevalence of elevated heart rate in oncology patients: a risk factor revisited.

Speaker: Doctor H. Aridi (Beirut, LB)

Access
Abstract
Slides
Like
Thumbnail

Endovascular treatment of ischemic heart disease in patients with blood cancer

Speaker: Doctor E. Gitelzon (Moscow, RU)

Access
Abstract
Slides
Like
Thumbnail

Cardio-renal interaction in young patients with Type 1 Diabetes Mellitus

Speaker: Miss N. Safarova (Hagen, DE)

Access
Abstract
Like
Thumbnail

Clinical impact of acute kidney injury in patients with acute coronary syndrome

Speaker: Doctor F. Fonseca Goncalves (Vila Real, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 4 - Cardiovascular Disease in Special Populations

Speakers: Miss J. Draper, Doctor Y. Kirichenko, Doctor H. Aridi, Doctor E. Gitelzon, Miss N. Safarova...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources